SBI Magnum Pharma Fund (G) NAV | SBI Mutual Fund | SBI Magnum Pharma Fund (G) Investment

	1 mth (%)	3 mth (%)	6 mth (%)	1 yr (%)	2 yr (%)	3 yr (%)	5yr (%)
Fund Returns	-1.4	7.8	10.3	10.3	12.7	25.5	6.6
Category avg	-2.3	5.8	7.2	5.1	9.8	27.1	12.9
Difference of Fund returns and Category returns	0.9	2.0	3.1	5.2	2.9	-1.6	-6.3
Best of category	-1.4	7.8	10.3	10.3	12.7	31.8	19.9
Worst of category	-2.8	3.5	3.1	1.5	7.9	23.9	6.6
Benchmark returns #	-1.9	6.3	11.9	10.0	12.7	24.1	12.1
Difference of Fund returns and Benchmark returns	0.5	1.5	-1.6	0.3	0.0	1.4	-5.5

# Benchmark Index: BSE HEALTHCARE

Investment Info

Investment Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.

Scheme details

Fund Type	Open-Ended
Investment Plan	Growth
Launch date	Jul 31, 1999
Benchmark	BSE HEALTHCARE
Asset Size (Rs cr)	41.05 (Mar-31-2012)
Minimum Investment	Rs.2000
Last Dividend	N.A. View Dividend History
Bonus	N.A.
Fund Manager	Tanmaya Desai View performance of schemes managed by the Fund Manager
Notes	N.A

Load Details

Entry Load	N.A
Exit Load	1.00%
Load Comments	Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment.

Contact Details

Regd. Office	191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No.	91 22 22180221/ 27
Fax No.	91 22 22189663
Email	partnerforlife@sbimf.com
Website	http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)
Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)	3mth (%)	6mth (%)	1yr (%)	3yr (%)	5yr (%)
Reliance Pharma Fund (G)	Not Ranked	563.56	6.0	8.1	3.4	31.8	19.9
SBI Magnum Pharma Fund (G)	Not Ranked	41.05	7.8	10.3	10.3	25.5	6.6
UTI Pharma & Health (G)	Not Ranked	93.37	3.5	3.1	1.5	23.9	12.3
* Returns over 1 year are Annualised	More »

Portfolio

Top Holdings (Apr 30, 12)

Equity	Sector	Value (Rs cr)	Asset %
Dr Reddys Labs	Pharmaceuticals	-	14.31
Cipla	Pharmaceuticals	-	10.86
Divis Labs	Pharmaceuticals	-	9.94
Lupin	Pharmaceuticals	-	9.87
Cadila Health	Pharmaceuticals	-	8.96
Ipca Labs	Pharmaceuticals	-	7.02
Torrent Pharma	Pharmaceuticals	-	6.79
Wyeth	Pharmaceuticals	-	6.26
Sun Pharma	Pharmaceuticals	-	4.90
Novartis India	Pharmaceuticals	-	3.28